Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)
Corticosteroids

FDA 2017

Corticosteroids, moderately potent (group II)

Desonide

Approved 28 Sept 2017TopicalLotion

The FDA lists this product in 20 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: DESONIDE 0.05%

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

DESONIDE 0.05% · LotionANDA213632-001 · Prescription
DESONIDE 0.05% · CreamANDA214396-001 · Prescription
DESONIDE 0.05% · OintmentANDA075751-001 · Prescription
DESONIDE 0.05% · LotionANDA202161-001 · Prescription
DESONIDE 0.05% · LotionThis page
DESONIDE 0.05% · OintmentANDA074254-001 · Prescription
DESONIDE 0.05% · OintmentANDA208836-001 · Discontinued
DESONIDE 0.05% · CreamANDA210198-001 · Prescription
DESONIDE 0.05% · OintmentANDA212473-001 · Prescription
DESONIDE 0.05% · LotionANDA209494-001 · Discontinued
DESONIDE 0.05% · OintmentANDA210998-001 · Prescription
DESONIDE 0.05% · CreamANDA209729-001 · Discontinued
DESONIDE 0.05% · OintmentANDA212002-001 · Discontinued

More in corticosteroids

Budesonide and Formoterol Fumarate Dihydratebudesonide · Aerosol, metered
Ciprofloxacin Hydrochloride and Hydrocortisoneciprofloxacin hydrochloride · Suspension/drops

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

DESONIDE 0.05% · CreamANDA073548-001 · Prescription

DESONIDE 0.05% · GelANDA202470-001 · Prescription

DESONIDE 0.05% · OintmentANDA209996-001 · Discontinued

DESONIDE 0.05% · LotionANDA075860-001 · Prescription

DESONIDE 0.05% · OintmentNDA017426-001 · Prescription

DESONIDE 0.05% · CreamANDA074027-001 · Prescription

DESONIDE 0.05% · CreamNDA017010-001 · Discontinued

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA207855.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Desonide
Drug class: Corticosteroids, moderately potent (group II), Corticosteroids, plain
Group: Corticosteroids
Route: Topical
Dosage form: Lotion
Applicant: Vertice
Status: Discontinued
FDA approval: 28 Sept 2017
Application: ANDA207855-001
RxCUI: 3254

Guidelines

Guidelines in endocrinology and metabolism950 guidelines in the library

FDA 2025

Pyquvideflazacort · Suspension

FDA 2025Khindivihydrocortisone · Solution

FDA 2025Jaytharideflazacort · Tablet

FDA 2024DeflazacortSuspension

FDA 2024Eohiliabudesonide · Suspension

FDA 2024TacrolimusCapsule, extended release

FDA 2024FluorometholoneSuspension/drops

FDA 2023BudesonideAerosol, foam

FDA 2023Airsupraalbuterol sulfate · Aerosol, metered

FDA 2021Tarpeyobudesonide · Capsule, delayed release

FDA 2021Oxymetazoline HydrochlorideCream

FDA 2021DifluprednateEmulsion

FDA 2021Formoterol FumarateSolution

FDA 2020Alkindi Sprinklehydrocortisone · Granule

FDA 2020Ciprofloxacin and Dexamethasoneciprofloxacin · Suspension/drops

FDA 2020Breztri Aerospherebudesonide · Aerosol, metered